Hi there and comfortable Friday, readers.
The Theranos debacle has now impressed a number of documentaries, podcasts, books, and deliberate characteristic movies. The query is: Will all this cross-media protection instill some knowledge within the well being sector?
Former Harvard Medical Faculty dean Dr. Jeffrey Flier is definitely making an attempt to unfold some classes. Harvard has been scrutinized by the renewed onslaught of media consideration for appointing Holmes to medical faculty’s board of fellows (Flier was dean on the time). Holmes had hoodwinked highly effective males and politicians with little information of well being technology–but what was Harvard’s excuse?
In a remarkably candid op-ed printed in BMJ, Flier tries to elucidate. And his insights carry up critical questions in regards to the function and construction of non-fiduciary boards at revered tutorial establishments.
Right here’s the important thing takeaway:
So what classes did I be taught from my involvement in Theranos-gate? Better due diligence is required, even for non-fiduciary boards just like the Harvard Medical Faculty Board of Fellows. Although this was by no means earlier than an issue, and in most circumstances like it will not have been–she may need develop into the subsequent Steve Jobs–broader socialization of latest members and higher deliberation is essential, maybe greater than I had realized. Then again, convincing nice folks to affix such boards is crucial to the well being of many not-for-profit establishments, and generally you should strike whereas the iron is scorching to interact them.
Learn on for the day’s information, and have an exquisite weekend.
Venrock: The well being IT market is frothy. The wizards over at Venrock are out with their newest report on the prognosis for well being care IT in 2019. The final takeaway? The consultants are optimistic–very, very optimistic. A hanging 78% of the report contributors suppose that the creation of latest well being IT firms will enhance both considerably or considerably this yr. One key issue that may very well be a buzzkill? Troubles with hiring expertise. You possibly can learn the total prognosis right here. (Venrock)
Bristol-Myers shareholders bless the debated Celgene deal. Bristol-Myers Squibb shareholders controlling 75% of the corporate’s inventory gave the inexperienced gentle to the corporate’s takeover bid for most cancers biotech Celgene, clearing the way in which for a deal that had confronted pushback from activist traders and criticism from a number of revered analysts. The deal is now anticipated to shut earlier than the top of the yr. (Axios)
THE BIG PICTURE
CDC houses in on E. coli outbreak supply. The Facilities for Illness Management could also be nearer to figuring out the foundation reason behind a latest E. coli outbreak that has unfold throughout a minimum of six states. The company believes that contaminated floor beef stands out as the supply, although the producer or distributor of the meat remains to be unknown. (Reuters)
China’s Employees Are Protesting Tech’s Lethal ‘996’ Additional time Tradition. Jack Ma Says He Requires It, by Lulu Yilun Chen & Bloomberg
From 80s Relic to IPO: The Unusual Story of Chuck E. Cheese, by Kate Flaim
Google’s Chief Variety Officer Is Out Amid Controversies, by Ellen McGirt
Shopping for a Tesla Is Going to Price You Extra, by Chris Morris
[ceo_attribution author=”Produced by Sy Mukherjee” email=”[email protected]” twitter=”the_sy_guy”] Discover previous protection. Join different Fortune newsletters.